Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Russo

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 26, 2018
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian centerStefania La Foresta, Cristina Faraone, Maria Sframeli, et al.
Brain Sciences|April 30, 2021
Patisiran in hATTR Amyloidosis: Six-Month Latency Period before EfficacyLuca Gentile, Massimo Russo, Marco Luigetti, et al.
Scientific Reports|September 24, 2020
The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosisMassimo Russo, Christian Lunetta, Riccardo Zuccarino, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 19, 2025
NfL as a biomarker in ATTRv amyloidosis: potential and limitationsMassimo Russo, M De Luca, L Gentile, et al.
Molecular Cancer Therapeutics|February 12, 2022
The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal MetastasesAlessia Anastasia, Giulia Dellavedova, Antonio Ramos-Montoya, et al.
The Canadian Journal of Cardiology|April 23, 2026
Clinical outcomes of Sirolimus coated balloons for the treatment of coronary disease. The Metal-Free registryGiuseppe Di Gioia, Marco Ferrone, Danilo Franco, et al.
Heart and Vessels|March 13, 2022
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) indexFabio Mangiacapra, Raffaele Rinaldi, Iginio Colaiori, et al.
Frontiers in Molecular Neuroscience|July 14, 2020
Circulating microRNAs Profile in Patients With Transthyretin Variant AmyloidosisGian Luca Vita, M'Hammed Aguennouz, Francesca Polito, et al.
Pharmacogenomics and Personalized Medicine|May 20, 2022
Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with PatisiranVincenzo Di Stefano, Antonella Fava, Luca Gentile, et al.
Frontiers in Neurology|February 27, 2023
Neuropathic pain experience in symptomatic and presymptomatic subjects carrying a transthyretin gene mutationStefano Tozza, Marco Luigetti, Giovanni Antonini, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 26, 2018
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian centerStefania La Foresta, Cristina Faraone, Maria Sframeli, et al.
Brain Sciences|April 30, 2021
Patisiran in hATTR Amyloidosis: Six-Month Latency Period before EfficacyLuca Gentile, Massimo Russo, Marco Luigetti, et al.
Scientific Reports|September 24, 2020
The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosisMassimo Russo, Christian Lunetta, Riccardo Zuccarino, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 19, 2025
NfL as a biomarker in ATTRv amyloidosis: potential and limitationsMassimo Russo, M De Luca, L Gentile, et al.
Molecular Cancer Therapeutics|February 12, 2022
The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal MetastasesAlessia Anastasia, Giulia Dellavedova, Antonio Ramos-Montoya, et al.
The Canadian Journal of Cardiology|April 23, 2026
Clinical outcomes of Sirolimus coated balloons for the treatment of coronary disease. The Metal-Free registryGiuseppe Di Gioia, Marco Ferrone, Danilo Franco, et al.
Heart and Vessels|March 13, 2022
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) indexFabio Mangiacapra, Raffaele Rinaldi, Iginio Colaiori, et al.
Frontiers in Molecular Neuroscience|July 14, 2020
Circulating microRNAs Profile in Patients With Transthyretin Variant AmyloidosisGian Luca Vita, M'Hammed Aguennouz, Francesca Polito, et al.
Pharmacogenomics and Personalized Medicine|May 20, 2022
Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with PatisiranVincenzo Di Stefano, Antonella Fava, Luca Gentile, et al.
Frontiers in Neurology|February 27, 2023
Neuropathic pain experience in symptomatic and presymptomatic subjects carrying a transthyretin gene mutationStefano Tozza, Marco Luigetti, Giovanni Antonini, et al.
Pageof 8